NIH Wants Your Take: Easier Apps for Trainees and Alumni
Published Date: 4/30/2026
Notice
Summary
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
You’ll Spend Time Filling NIH Forms
If you apply to or register for NIH training programs, there are no monetary fees but you must spend time filling forms. The notice estimates a total annualized respondent burden of 14,311 hours across activities, and invites public comments within 60 days of April 30, 2026; OMB approval is requested for 3 years.
NIH Will Collect Certain Sensitive Data
The application and registration forms collect sensitive information including race/ethnicity, sex, relatives at NIH, and recruitment method. That sensitive data is provided only to select OITE staff or in aggregate to select NIH offices, and is not provided to admission committees for review.
Forms Tailored to Specific Training Programs
NIH will use template-based forms that can be enabled or labeled for specific programs (for example, SIP, PBP, GPP, UGSP, and FARE) and will collect categories like personal info, education history, references, resumes, research abstracts, and onboarding/offboarding feedback. Templates allow program-specific labeling and directions so each collection can be tailored to that training program.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
2026-08142 — Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on May 29, 2026, to share updates and review important research projects. The first half is open to the public, while the second half is private to discuss grant applications and staff performance. This meeting affects researchers and the public interested in child health, with no direct cost changes but important decisions on funding and personnel.
Previous / Next Documents
Previous: 2026-08455 — ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing
The FDA wants to take back its approval of the drug TAVNEOS, made by ChemoCentryx, because new info shows it might not work as promised and some facts in the application weren’t true. ChemoCentryx can ask for a hearing by June 1, 2026, to defend their drug. This could affect patients using TAVNEOS and might impact the company’s sales and future plans.
Next: 2026-08457 — Transcontinental Gas Pipe Line Company, LLC; Notice of Request Under Blanket Authorization and Establishing Intervention and Protest Deadline
Transcontinental Gas Pipe Line Company wants to build three new gas delivery stations and upgrade one in Texas, plus expand a valve site in Louisiana. This project will boost gas delivery by 115,000 dekatherms daily and costs nearly $29 million. If you’re interested, you’ve got until the protest deadline to speak up or get involved!